BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2122047)

  • 41. Effects of lipoprotein(a) on thrombolysis.
    von Hodenberg E; Pestel E; Kreuzer J; Freitag M; Bode C
    Chem Phys Lipids; 1994 Jan; 67-68():381-5. PubMed ID: 8187238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short- and long-term mortality of intracoronary urokinase in acute myocardial infarction].
    Nagao K; Kikuchi S; Kanmatsuse K; Kanmatsuse K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):790-6. PubMed ID: 12436617
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thrombolytic therapy of acute myocardial infarction--effects, problems and their strategies].
    Nagao K; Kanmatsuse K; Kajiwara N
    Jpn Circ J; 1992; 56 Suppl 5():1406-8. PubMed ID: 1291730
    [No Abstract]   [Full Text] [Related]  

  • 44. [Thrombolytic therapy with tissue-type plasminogen activator].
    Toma M; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
    [No Abstract]   [Full Text] [Related]  

  • 45. [Short and long-term effects of coronary thrombolysis in acute myocardial infarction].
    Motomiya T; Tokuyasu Y; Sakurada H; Yanase O; Nomura S; Tejima T; Hiyoshi Y; Sugiura M
    Jpn Circ J; 1992; 56 Suppl 5():1409-13. PubMed ID: 1291731
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mutant t-PA compared with native t-PA in acute myocardial infarction].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():453-6. PubMed ID: 12735014
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemorheological factors in the management of myocardial infarct--use of urokinase].
    Kiso T; Harada H; Kawasaki T; Kishima N; Sano I; Fukuda I; Seki I; Mozai T
    Nihon Rinsho; 1979; 37(2):430-40. PubMed ID: 439432
    [No Abstract]   [Full Text] [Related]  

  • 48. [Coronary thrombolytic agents and their characteristics].
    Yoshinaga M; Kambara H
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):775-81. PubMed ID: 12436615
    [No Abstract]   [Full Text] [Related]  

  • 49. [Coagulation factors, platelets and coronary heart disease].
    Rasi V; Salomaa V; Pekkanen J
    Duodecim; 1991; 107(15):1277-85. PubMed ID: 1365350
    [No Abstract]   [Full Text] [Related]  

  • 50. Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction.
    Fujita M; Araie E; Yamanishi K; Miwa K; Kida M; Nakajima H
    Am J Cardiol; 1993 Jun; 71(15):1369-71. PubMed ID: 8498385
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical significance of the fibrinolysis system].
    Himmelreich G; Riess H
    Dtsch Med Wochenschr; 1991 Mar; 116(11):426-30. PubMed ID: 1900466
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute myocardial infarction shortly after negative exercise test and reperfusion by intracoronary thrombolysis.
    Kurata C; Sakata K; Taguchi T; Kobayashi A; Yamazaki N
    Jpn Circ J; 1989 Nov; 53(11):1382-8. PubMed ID: 2621767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

  • 54. Intracoronary urokinase and post-thrombolytic regimen in an infant with Kawasaki disease and acute myocardial infarction.
    Katayama F; Hiraishi S; Takeda N; Misawa H
    Heart; 1997 Dec; 78(6):621-2. PubMed ID: 9470886
    [No Abstract]   [Full Text] [Related]  

  • 55. Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction.
    Armstrong VW; Neubauer C; Schütz E; Tebbe U
    Lancet; 1990 Oct; 336(8722):1077. PubMed ID: 1977059
    [No Abstract]   [Full Text] [Related]  

  • 56. [Early occlusion of the infarct-related artery after emergency PTCA for acute myocardial infarction].
    Shirotani M; Yui Y; Hattori R; Kawai C
    Jpn Circ J; 1992; 56 Suppl 5():1421-4. PubMed ID: 1291734
    [No Abstract]   [Full Text] [Related]  

  • 57. Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases.
    Sawin PD; Traynelis VC; Follett KA
    J Neurosurg; 1995 Aug; 83(2):350-3. PubMed ID: 7616284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progression of study on treatment of acute myocardial infarction with thrombolysis therapy of integrated tradition Chinese and Western medicine].
    Yang CH; Lu F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):73-5. PubMed ID: 12585179
    [No Abstract]   [Full Text] [Related]  

  • 59. Augmented plasma protein C activity after coronary thrombolysis with urokinase in patients with acute myocardial infarction.
    Goto S; Handa S; Kawai Y; Watanabe K; Abe S; Takahashi E; Hori S; Ikeda Y
    Cardiology; 1992; 80(3-4):252-6. PubMed ID: 1387346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrinolytic therapy urokinase for myocardial infarction.
    Nakano M
    Angiology; 1983 Oct; 34(10):654-73. PubMed ID: 6625222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.